Avet Pharmaceuticals introduces Propofol Injectable Emulsion single use vials in US
8 April 2022 -

United States-based Avet Pharmaceuticals Inc. announced on Thursday that it has launched its Propofol Injectable Emulsion, USP 10mg/mL, in 20, 50 and 100ml Single Patient-Use Vials, an AB rated generic equivalent of DIPRIVAN(R) (propofol) Injectable Emulsion USP, in the United States.

The product has been launched subsequent to its abbreviated new drug application approval from the United States Food and Drug Administration (FDA). It is an intravenous general anaesthetic and sedation drug. The product is a trademark of Fresenius Kabi USA, LLC.

Avet Pharmaceuticals said that it will start distribution of the product immediately.